Home / Product Catalog...

Product Catalog (Universal Version) of Kexing Biopharm

Article source：

Sep 29,2026

View： 1533

LABEL:

Related News

Kexing Biopharm's Independently Developed Ophthalmic Innovative Drug GB10 Receives Clinical Trial Approval

Kexing Biopharm's Independently Developed Ophthalmic Innovative Drug GB10 Receives Clinical Trial Approval

Kexing Biopharm’s Overseas Products Bevacizumab and Sorafenib Approved for Marketing in Syria

Kexing Biopharm’s Overseas Products Bevacizumab and Sorafenib Approved for Marketing in Syria

Kexing Biopharm's Completion of the First Dose of Its Long-acting GC Product in Subjects in Phase 1 Clinical Study for In-depth Layout of WBC-Stimulating Drug Market

Kexing Biopharm's Completion of the First Dose of Its Long-acting GC Product in Subjects in Phase 1 Clinical Study for In-depth Layout of WBC-Stimulating Drug Market

Kexing Biopharm's Overseas Commercial Product——Liraglutide, Has Received GMP Rertification from Brazil

Kexing Biopharm's Overseas Commercial Product——Liraglutide, Has Received GMP Rertification from Brazil

Kexing Biopharm’s Generic Paclitaxel (Albumin-bound) Approved in Uruguay

Kexing Biopharm’s Generic Paclitaxel (Albumin-bound) Approved in Uruguay

Kexing Biopharm Partners with BioDlink to Embark on Latin American Markets

Kexing Biopharm Partners with BioDlink to Embark on Latin American Markets